Repositioning Candidate Details

Candidate ID: R0615
Source ID: DB04743
Source Type: approved; investigational; withdrawn
Compound Type: small molecule
Compound Name: Nimesulide
Synonyms: Nimesulide
Molecular Formula: C13H12N2O5S
SMILES: CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
Structure:
DrugBank Description: Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.
CAS Number: 51803-78-2
Molecular Weight: 308.31
DrugBank Indication: For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old.
DrugBank Pharmacology: Food, gender and advanced age have negligible effects on nimesulide pharmacokinetics.
DrugBank MoA: The therapeutic effects of Nimesulide are the result of its complete mode of action which targets a number of key mediators of the inflammatory process such as: COX-2 mediated prostaglandins, free radicals, proteolytic enzymes and histamine.
Targets: Prostaglandin G/H synthase 2 inhibitor; Group IIE secretory phospholipase A2; Lactotransferrin
Inclusion Criteria: Therapeutic strategy associated